
Retatrutide
Triple hormone receptor agonist research category focused on GLP-1, GIP, and glucagon receptor pathways.
View research overviewProduct catalog
Explore Primo Labs product availability and beginner-friendly research education in one place. This catalog is informational only and does not provide dosing schedules, medical protocols, or treatment advice.
Available Catalog
Listed sizes are catalog identifiers for research education and inventory presentation. They are not dosing recommendations.

Triple hormone receptor agonist research category focused on GLP-1, GIP, and glucagon receptor pathways.
View research overview
Dual GIP and GLP-1 receptor agonist research category for educational metabolic-science discussion.
View research overview
Mitochondrial-derived peptide research category associated with metabolism, insulin sensitivity, and exercise pathways.
View research overview
Precision-formulated 70mg research peptide blend composed of GHK-Cu, BPC-157, and TB-500.
View product infoRetatrutide is an investigational triple receptor agonist currently being explored in metabolic and obesity-focused research environments. The compound is designed to interact with GLP-1, GIP, and glucagon receptor pathways, generating significant interest within the scientific community for its potential role in appetite regulation, energy expenditure, and metabolic adaptation models.
Tirzepatide is a dual-pathway incretin research category that targets both GIP and GLP-1 receptor activity. It has become a major topic within metabolic-health, glucose-regulation, and appetite-signaling discussions due to its role in advancing obesity and diabetes-related research.
MOTS-c is a mitochondrial-derived peptide currently being investigated for its potential involvement in cellular metabolism, insulin signaling, exercise adaptation, and inflammatory-response pathways. Interest in MOTS-c has expanded within longevity and performance-research communities, though human data remains limited.
GLOW 70mg commonly refers to a precision-formulated peptide research blend containing a total of 70mg of combined active ingredients. The blend is typically composed of three widely discussed research peptides: GHK-Cu, BPC-157, and TB-500. Within research and wellness communities, the formulation is frequently associated with regenerative, recovery, and skin-quality research models.
Primo Labs does not provide medical advice, diagnosis, or treatment. All information is educational only. Catalog sizes are not dosing recommendations. Catalog items are research chemicals and are not intended for human consumption.
Contact
For product availability, educational questions, or general inquiries, fill out the form below and we'll get back to you.